MIRA INFORM REPORT

 

 

Report No. :

498184

Report Date :

19.03.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

JUBILANT GENERICS LIMITED

 

 

Registered Office :

Plot 1A, Sector 16A, Institutional Area, Gautam Budha Nagar, Noida - 201301, Uttar Pradesh

Tel. No.:

91-120-4361000

 

 

Country :

India

 

 

Financials (as on) :

31.03.2016

 

 

Date of Incorporation :

25.11.2013

 

 

Com. Reg. No.:

20-060821

 

 

Capital Investment / Paid-up Capital :

INR 13.080 Million

 

 

CIN No.:

[Company Identification No.]

U24100UP2013FLC060821

 

 

IEC No.:

[Import-Export Code No.]

Not Divulged

 

 

TIN No.:

09665719785

 

 

PAN No.:

[Permanent Account No.]

AADCJ2401L

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Divulged

 

 

GSTN :

[Goods & Service Tax Registration No.]

09AADCJ2401L1ZO

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Subject is to engage in the manufacture and supply of Generics (including Active Pharmaceutical Ingredients (APIs) and Solid Dosage Formulations).  (Registered Activity)

 

 

No. of Employees :

Not Divulged

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A+

 

Credit Rating

Explanation

Rating Comments

A+

Low Risk

Business dealings permissible with low risk of default

 

Maximum Credit Limit :

USD 18496000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is wholly owned subsidiary of “Jubilant Pharma Limited, Singapore” and was incorporated in the year 2013. It is having fine track records.

 

As per the registrar of Companies date of balance sheet (i.e. financial filed) is shown as 31.03.2017 but documents related to financial for the year 31.03.2017 are not available from any sources.

 

For the financial year 2016, the company has increased its revenue from operation as compared to previous year and reported average profitability margin of 2.03%.

 

Rating takes into consideration sound financial profile of the company marked by healthy networth base and average debt balance sheet.

 

Further, the company also derives strength from its strong holding company support, well established track records of business operation along with improvement in the profitability and market position.

 

Trade relations are reported as fair. Business is active. Payments terms are reported to be regular.

 

In view of the aforesaid, the company can be considered for business dealings at usual trade terms and conditions. 

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.09.2017)

Current Rating

(31.12.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

INDIA RATING

Rating

Long term rating : AA-

Rating Explanation

High degree of safety and very low credit risk

Date

September, 2017

 

Rating Agency Name

INDIA RATING

Rating

Short term rating : A1+

Rating Explanation

Very strong degree of safety and carry lowest credit risk

Date

September, 2017

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 19.03.2018

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

INFORMATION DECLINED

 

Management non-cooperative (Tel No.: 91-120-4361000)

 

LOCATIONS

 

Registered Office/ Corporate Office :

Plot 1A, Sector 16A, Institutional Area, Gautam Budha Nagar, Noida - 201301, Uttar Pradesh, India

Tel. No.:

91-120-4361000

Fax No.:

91-120-4234881/84/85 87/95/96

E-Mail :

amit_chaurasia@jubl.com

Website :

http://www.jubl.com

 

 

Factory 1/ R & D Facilities 1 :

Bhartiagram Gajraula, District Amroha - 244223, Uttar Pradesh, India

Tel. No.:

91-5924-252353-60

Fax No.:

91-5924-252352

 

 

Factory 2 :

Village Sikandarpur Bhainswal, Bhagwanpur, Roorkee, District Haridwar-247661, Uttarakhand, India

Tel. No.:

91-1332-235161-66

Fax No.:

91-1332-235169

 

Factory 3 / R & D Facilities 2 :

56, Industrial Area, Nanjangud, District Mysore - 571302, Karnataka, India

Tel. No.:

91-8221-228402-08

Fax No.:

91-8221-228410-11

 

 

Factory 4 :

Block 133, Village Samlaya, Taluka Savli, District Vadodara - 391520, Gujarat, India

Tel. No.:

91-2667-251361, 251 563-4

Fax No.:

91 2667-251305

 

 

Factory 5 :

Plot No.5, Vilayat GIDC, Taluka Vagra, Bharuch - 392012, Gujarat, India

Tel. No.:

91-2641-281500 (30 Lines)

Fax No.:

91-2641-281515

 

 

Factory 6 :

Village Nimbut, Railway Station, Nira Taluka Baramati, Pune-412102, Maharashtra, India

Tel. No.:

91-2112-269155

 

 

Factory 7 :

N-34, Additional Ambernath MIDC Anand Nagar, Ambernath (East)-421506, Maharashtra, India

 

 

R & D Facilities 3 :

C-46, Sector 62, Noida - 201 301, Uttar Pradesh, India

Tel. No.:

91-120-4364000

Fax No.:

91-120-2404336

 

 

Branch Offices :

Located at :

 

  • Uttar Pradesh
  • Tamilnadu
  • Telangana
  • Karnataka
  • Maharashtra
  • Gujarat
  • West Bengal

 

 

DIRECTORS

 

As on 31.03.2017

 

Name :

Mr. Shyam Nath Singh

Designation :

Director

Address :

301, Konark Apartments, Patparganj, Delhi 110092, India

Date of Birth/Age :

12.06.1938

Date of Appointment :

29.09.2015

PAN No.:

ANUPS0207N

DIN No.:

00010530

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U24232UP2004PLC029008

JUBILANT CLINSYS LIMITED

23/08/2013

-

U24232UP2004PLC029009

JUBILANT CHEMSYS LIMITED

03/08/2012

-

U24119UP1998PLC037398

SPECIALITY MOLECULES LIMITED

25/09/2008

-

U24110UP1998PLC029591

JUBILANT BIOSYS LIMITED

27/06/2003

-

U85110UP2006PLC035993

JUBILANT FIRST TRUST HEALTHCARE LIMITED

17/07/2015

-

U73100UP2009PTC037333

VANTHYS PHARMACEUTICAL DEVELOPMENT PRIVATE LIMITED

31/08/2015

-

U74120UP2013PTC054822

JUBILANT ENPRO PRIVATE LIMITED

30/09/2016

-

U45201UP2006PLC031618

JUBILANT INFRASTRUCTURE LIMITED

24/08/2012

-

 

 

Name :

Mr. Rajagopal Sankaraiah

Designation :

Director

Address :

B4/11, DLF Phase - I, Gurugram-122002, Haryana, India

Date of Birth/Age :

07.05.1959

Date of Appointment :

25.11.2013

PAN No.:

AAVPS4387H

DIN No.:

00025022

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U24110UP1998PLC029591

JUBILANT BIOSYS LIMITED

23/08/2013

-

U85110UP2007PTC059859

FIRST TRUST MEDICARE PRIVATE LIMITED

27/08/2012

-

U74900UP2007NPL033244

JUBILANT BHARTIA FOUNDATION

03/05/2007

-

U73100UP2007PLC034211

JUBILANT INNOVATION (INDIA) LIMITED

29/11/2007

-

U73100UP2009PTC037333

VANTHYS PHARMACEUTICAL DEVELOPMENT PRIVATE LIMITED

11/05/2009

-

U24119UP1998PLC037398

SPECIALITY MOLECULES LIMITED

25/09/2008

-

U64201DL2005PTC140907

BT TELECOM INDIA PRIVATE LIMITED

20/05/2015

-

 

 

Name :

Ms. Sudha Pillai

Designation :

Director

Address :

D-241, Second Floor, Sarvodaya Enclave, New Delhi-110017, India

Date of Birth/Age :

01.05.1950

Date of Appointment :

29.09.2015

PAN No.:

AENPP4151N

DIN No.:

02263950

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U28910PB1990PLC010265

AMBER ENTERPRISES INDIA LIMITED

20/09/2017

-

U65191TN1994PLC079235

FULLERTON INDIA CREDIT COMPANY LIMITED

20/08/2014

-

U65191TN1996PLC035963

DALMIA CEMENT (BHARAT) LIMITED

29/09/2015

-

L63040DL1981PLC011941

INTERNATIONAL TRAVEL HOUSE LIMITED

10/09/2014

-

U74899DL1994PTC061471

PICL (INDIA) PRIVATE LIMITED

26/09/2017

-

L24116UP1978PLC004624

JUBILANT LIFE SCIENCES LIMITED

02/09/2014

-

L40109TN2006PLC058818

DALMIA BHARAT LIMITED

30/09/2015

-

L26942TN1949PLC117481

OCL INDIA LIMITED

18/09/2015

-

 

 

Name :

Mr. Gurpartap Singh Sachdeva

Designation :

Director

Address :

14 Sparrow Dr Princeton JCT New Jersey 08550 US

Date of Appointment :

27.10.2015

DIN No.:

07288795

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U74900UP2009FLC038194

JUBILANT DRAXIMAGE LIMITED

26/08/2016

-

 


 

KEY EXECUTIVES

 

Name :

Mr. Amit Chaurasia

Designation :

Company Secretary

Address :

K-22, Second Floor, Naveen Shahdara, Delhi-110032, India

Date of Birth/Age :

28.02.1977

Date of Appointment :

10.12.2013

PAN No.:

AEMPC9499M

 

 

MAJOR SHAREHOLDERS

 

As on 31.03.2017

 

Names of Shareholders

 

No. of Shares

Jubilant Pharma Limited, Singapore

 

2579658

Jubilant Phan1Ja Limited jointly with R. Sankaraiah.

 

1

Jubilant Phan1Ja Limited jointly with Prakash 13isht

 

1

Jubilant Phanna Limited jointly with Arun Sharma

 

1

Jubilant Phanna Limited jointly with Rajiv Shah

 

1

Jubilant Phanna Limited jointly with Ambuj Jain

 

1

Jubilant Pharma Limited jointly with Praveen Gupta,

 

1

Jubilant Pharma Limited jointly with Ashwani Malhotra

 

1

Total

 

2579665

 

Equity Share Break up (Percentage of Total Equity)

 

As on 28.08.2017

 

Category

Percentage

Promoters (Body corporate)

100.00

Total 

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Subject is to engage in the manufacture and supply of Generics (including Active Pharmaceutical Ingredients (APIs) and Solid Dosage Formulations).  (Registered Activity)

 

 

Products / Services :

Item Code No.

Products/Services Description

99814001

Pharmaceuticals

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged 

 

 

Imports :

Not Divulged 

 

 

Terms :

Not Divulged 

 

PRODUCTION STATUS – (NOT AVAILABLE)

 

 

GENERAL INFORMATION

 

Suppliers :

 

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

Customers :

 

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

No. of Employees :

Not Divulged

 

 

Bankers :

Banker Name :

IndusInd Bank Limited

Branch :

2401, Gen Thimmayya Road, Contonment, Pune-411001, Maharashtra, India

Person Name (With Designation) :

--

Contact Number :

--

Name of Account Holder :

--

Account Number :

--

Account Since (Date/Year of Account Opening) :

--

Average Balance Maintained :

--

Credit Facilities Enjoyed (CC/OD/Term Loan) :

--

Account Operation :

--

Remark :

--

 

 

Facilities :

Secured Loan

31.03.2016

(INR in Million)

31.03.2015

(INR in Million)

Long-term Borrowings

 

 

Rupee term loans from banks

3343.010

3575.000

Rupee term loans from others

750.000

0.000

Long-term maturities of finance lease

obligations

5.040

1.540

Short-term borrowings

 

 

Loans repayable on demand from banks

2213.260

1165.510

Loans repayable on demand from others

284.490

274.200

Total

6595.800

5016.250

 

Auditors :

 

Name :

BSR and Company LLP

Chartered Accountants

Address :

Building No.10, 8th Floor, Tower-B, DLF Cyber City, Phase-II, Gurugram -122002, Haryana, India

Income-tax PAN of auditor or auditor's firm :

AAAFB9852F

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

 

 

Holding Company  (As on 2017) :

  • Jubilant Pharma Limited
  • Jubilant Life Sciences Limited

CIN No.: L24116UP1978PLC004624

 

 

Subsidiary Companies (As on 2017) :

  • Jubilant Pharma NV
  • Jubilant Pharmaceuticals NV
  • PSI Supply NV

 

 

Holding Company (As on 31.03.2016) :

  • Jubilant Pharma Limited

 

 

Ultimate Holding Company (As on 31.03.2016) :

  • Jubilant Life Sciences Limited

CIN No.: L24116UP1978PLC004624

 

 

Fellow Subsidiaries (As on 31.03.2016) :

  • Jubilant HollisterStier LLC
  • Jubilant Biosys Limited
  • Jubilant Cadista Pharmaceuticals Inc.
  • Jubilant Chemsys Limited
  • Jubilant Clinsys Limited
  • Jubilant DraxImage Inc.
  • Jubilant Pharma Holdings Inc.
  • Jubilant Pharma Trading Inc.
  • Jubilant Life Sciences (USA) Inc.
  • Jubilant Clinsys Inc.

 

 

Subsidiary (As on 31.03.2016) :

  • Jubilant Pharma NV

 

 

Step-down Subsidiaries (As on 31.03.2016) :

  • Jubilant Pharmaceuticals NV
  • PSI Supply NV

 

 

Other Entities (As on 31.03.2016) :

  • Jubilant HollisterStier General Partnership
  • Jubilant Agri and Consumer Products Limited
  • Vam Employees Provident Fund Trust

 

 

CAPITAL STRUCTURE

 

As on 28.08.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

3000000

Equity Shares

INR 10/- each

INR 30.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

2579665

Equity Shares

INR 10/- each

INR 25.797 Million

 

 

 

 

 

 

As on 31.03.2016

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

2000000

Equity Shares

INR 10/- each

INR 20.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1308499

Equity Shares

INR 10/- each

INR 13.080 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are INR Million]

 

ABRIDGED BALANCE SHEET (STANDALONE)

 

SOURCES OF FUNDS

31.03.2016

31.03.2015

31.03.2014

I.      EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

13.080

9.230

1.000

(b) Reserves and Surplus

6460.540

3287.890

(0.410)

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

6473.620

3297.120

0.590

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

8439.050

7917.540

0.000

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long-term liabilities

102.440

82.110

0.000

(d) long-term provisions

174.680

166.800

0.000

Total Non-current Liabilities (3)

8716.170

8166.450

0.000

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short-term borrowings

2497.750

1439.710

0.000

(b) Trade payables

1599.180

1187.240

0.140

(c) Other current liabilities

999.120

5676.230

0.030

(d) Short-term provisions

61.400

14.550

0.000

Total Current Liabilities (4)

5157.450

8317.730

0.170

 

 

 

 

TOTAL

20347.240

19781.300

0.760

 

 

 

 

II.    ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

5702.170

6064.850

0.000

(ii) Intangible Assets

2329.400

2394.370

0.000

(iii) Tangible assets capital work-in-progress

160.520

60.440

0.000

(iv) Intangible assets under development

2807.630

2723.100

0.000

(b) Non-current Investments

4055.000

4055.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d) Long-term loans and advances

80.270

84.460

0.000

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

15134.990

15382.220

0.000

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

2122.210

1878.320

0.000

(c) Trade receivables

2296.180

2063.240

0.000

(d) Cash and bank balances

38.060

24.670

0.760

(e) Short-term loans and advances

753.130

424.560

0.000

(f) Other current assets

2.670

8.290

0.000

Total Current Assets

5212.250

4399.080

0.760

 

 

 

 

TOTAL

20347.240

19781.300

0.760

 

 

PROFIT & LOSS ACCOUNT (STANDALONE)

 

 

PARTICULARS

31.03.2016

31.03.2015

31.03.2014

 

SALES

 

 

 

 

Revenue from operations

9104.220

6203.290

0.000

 

Other Income

9.590

10.710

0.000

 

TOTAL

9113.810

6214.000

0.000

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

3524.700

2746.310

0.000

 

Purchases of Stock-in-Trade

30.380

44.420

0.000

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(182.550)

(148.540)

0.000

 

Employee benefit expense

1219.520

857.400

0.000

 

Other expenses

1802.190

1499.710

0.410

 

TOTAL

6394.240

4999.300

0.410

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

2719.570

1214.700

(0.410)

 

 

 

 

 

Less

FINANCIAL EXPENSES

1096.620

1107.450

0.000

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

1622.950

107.250

(0.410)

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

1390.310

928.120

0.000

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

232.640

(820.870)

(0.410)

 

 

 

 

 

Less

TAX

47.740

0.000

0.000

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

184.900

(820.870)

(0.410)

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

169.68

(1032.69)

(14.64)

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2016

31.03.2015

31.03.2014

Current Maturities of Long term debt

48.650

725.000

0.000

Cash generated from operations

NA

NA

NA

Net cash flows from (used in) operations

2483.590

521.470

(0.240)

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Average Collection Days

(Sundry Debtors / Income * 365 Days)

92.06

121.40

0.00

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

3.96

3.01

0.00

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

164.19

155.28

0.00

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

1.28

0.65

0.00

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

0.25

0.11

0.00

 

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.67

0.86

0.22

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

1.70

3.06

0.00

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

0.80

2.52

0.29

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

1.70

3.41

0.00

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

2.48

1.10

0.00

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2016

31.03.2015

31.03.2014

Net Profit Margin

((PAT / Sales) * 100)

%

2.03

(13.23)

0.00

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

0.91

(4.15)

(53.95)

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

2.86

(24.90)

(69.49)

 

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Current Ratio

(Current Assets / Current Liabilities)

1.01

0.53

4.47

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

0.60

0.30

4.47

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.32

0.17

0.78

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

839.87

1092.33

0.00

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

1.01

0.53

4.47

 

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

FINANCIAL ANALYSIS

[all figures are in INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2014

31.03.2015

31.03.2016

 

(INR In Million)

(INR In Million)

(INR In Million)

Share Capital

1.000

9.230

13.080

Reserves & Surplus

(0.410)

3287.890

6460.540

Net worth

0.590

3297.120

6473.620

 

 

 

 

long-term borrowings

0.000

7917.540

8439.050

Short term borrowings

0.000

1439.710

2497.750

Current maturities of long-term debts

0.000

725.000

48.650

Total borrowings

0.000

10082.250

10985.450

Debt/Equity ratio

0.000

3.058

1.697

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

 

(INR In Million)

(INR In Million)

Sales

6203.290

9104.220

 

 

46.764

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

 

(INR In Million)

(INR In Million)

Sales

6203.290

9104.220

Profit/ (Loss)

(820.870)

184.900

(13.23%)

2.03%

 

 

 

 

ABRIDGED BALANCE SHEET (CONSOLIDATED)

 

SOURCES OF FUNDS

 

 

31.03.2016

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

 

13.080

(b) Reserves & Surplus

 

 

6338.850

(c) Money received against share warrants

 

 

0.000

 

 

 

 

(2) Share Application money pending allotment

 

 

0.000

(3) Minority Interest

 

 

234.580

Total Shareholders’ Funds

 

 

6586.510

 

 

 

 

(4) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

 

8439.050

(b) Deferred tax liabilities (Net)

 

 

0.000

(c) Other long term liabilities

 

 

102.440

(d) long-term provisions

 

 

175.970

Total Non-current Liabilities

 

 

8717.460

 

 

 

 

(5) Current Liabilities

 

 

 

(a) Short term borrowings

 

 

2497.750

(b) Trade payables

 

 

1617.440

(c) Other current liabilities

 

 

1019.740

(d) Short-term provisions

 

 

65.080

Total Current Liabilities (4)

 

 

5200.010

 

 

 

 

TOTAL

 

 

20503.980

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

 

5702.350

(ii) Intangible Assets

 

 

3432.240

(iii) Capital work-in-progress

 

 

160.520

(iv) Intangible assets under development

 

 

2806.640

(b) Non-current Investments

 

 

3090.000

(c) Deferred tax assets (net)

 

 

0.000

(d)  Long-term Loan and Advances

 

 

80.540

(e) Other Non-current assets

 

 

0.000

Total Non-Current Assets

 

 

15272.290

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

 

0.000

(b) Inventories

 

 

2144.380

(c) Trade receivables

 

 

2232.990

(d) Cash and cash equivalents

 

 

72.370

(e) Short-term loans and advances

 

 

779.280

(f) Other current assets

 

 

2.670

Total Current Assets

 

 

5231.690

 

 

 

 

TOTAL

 

 

20503.980

 

PROFIT & LOSS ACCOUNT (CONSOLIDATED)

 

 

PARTICULARS

 

 

31.03.2016

 

SALES

 

 

 

 

Income

 

 

9204.370

 

Other Income

 

 

9.890

 

TOTAL

 

 

9214.260

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

 

 

3524.700

 

Purchases of Stock-in-Trade

 

 

48.980

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

 

 

(152.210)

 

Employees benefits expense

 

 

1247.000

 

Other expenses

 

 

1880.380

 

TOTAL

 

 

6548.850

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

 

 

2665.410

 

 

 

 

 

Less

FINANCIAL EXPENSES

 

 

1096.790

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

 

 

1568.620

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

 

 

1390.800

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

 

 

177.820

 

 

 

 

 

Less

TAX

 

 

47.820

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX 

 

 

130.000

 

 

 

 

 

Add

Minority Interest

 

 

14.540

 

 

 

 

 

 

PROFIT / (LOSS) FOR THE YEAR

 

 

144.540

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

 

 

132.65

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of establishment

Yes

2]

Constitution of the entity Incorporation details

Yes

3]

Locality of the entity

Yes

4]

Premises details

No

5]

Buyer visit details

--

6]

Contact numbers

Yes

7]

Name of the person contacted

No

8]

Designation of contact person

No

9]

Promoter’s background

Yes

10]

Date of Birth of Proprietor / Partners / Directors

Yes

11]

Pan Card No. of Proprietor / Partners

Yes

12]

Voter Id Card No. of Proprietor / Partners

No

13]

Type of business

Yes

14]

Line of Business

Yes

15]

Export/import details (if applicable)

No

16]

No. of employees

No

17]

Details of sister concerns

Yes

18]

Major suppliers

No

19]

Major customers

No

20]

Banking Details

Yes

21]

Banking facility details

Yes

22]

Conduct of the banking account

--

23]

Financials, if provided

Yes

24]

Capital in the business

Yes

25]

Last accounts filed at ROC, if applicable

No

26]

Turnover of firm for last about two years months

Yes

27]

Reasons for variation <> 20%

--

28]

Estimation for coming financial year

No

29]

Profitability for last about two years months

Yes

30]

Major shareholders, if available

Yes

31]

External Agency Rating, if available

Yes

32]

Litigations that the firm/promoter involved in

--

33]

Market information

--

34]

Payments terms

No

35]

Negative Reporting by Auditors in the Annual Report

No

 

 

CORPORATE INFORMATION (As on 31.03.2016)

 

The Company is a public limited company domiciled in India and incorporated on 25 November 2013 under the provisions of Companies Act, 1956. The Company is incorporated to engage in the manufacture and supply of Generics (including Active Pharmaceutical Ingredients (APIs) and Solid Dosage Formulations).

 

 

RESULTS OF OPERATIONS AND THE STATE OF COMPANY’S AFFAIRS (As on 31.03.2016)

 

Income from Operations

 

In the Financial Year 2015-16, the Company recorded income from operations of INR 9104.220 million.

 

International Revenues

 

International business contributed 86% to the Net Revenue from operations at INR 7816.780 million.

 

EBITDA

 

For the year ended March 31, 2016, EBITDA stood at INR 2719.570 million with EBITDA margins at 30%.

 

Reported Net Profit/ Loss After Tax and EPS

 

Reported Net Profit After Tax was INR 184.900 million in the Financial Year 2015-16. Basic EPS stood at INR 169.68.

 

UNSECURED LOAN

 

PARTICULARS

31.03.2016

(INR in Million)

31.03.2015

(INR in Million)

Long-term Borrowings

 

 

Fully convertible debentures others

4341.000

4341.000

Total

4341.000

4341.000

 

 

INDEX OF CHARGES

 

S

No

SRN

Charge Id

Charge Holder Name

Date of Creation

Date of Modification

Date of Satisfaction

Amount

Address

1

C39989314

10542119

ICICI BANK LIMITED

09/01/2015

-

-

5000000000.0

ICICI BANK TOWERS BANDRA KURLA COMPLEX MUMBAI MAHARASHTRA 400051 INDIA

2

G31205099

10622549

INDUSIND BANK LIMITED

05/02/2016

-

21/12/2016

1000000000.0

2401 GEN THIMMAYYA ROAD CONTONMENT PUNE MAHARASHTRA 411001 INDIA

3

G30984025

10532814

IL & FS TRUST COMPANY LIMITED

30/09/2014

20/03/2015

14/12/2016

1300000000.0

IL & FS FINANCIAL CENTRE PLOT NO C22 G BLOCK BANDRA KURLA COMPLEX BANDRA EAST MUMBAI MAHARASHTRA 400051 INDIA

4

G30983183

10517564

IL & FS TRUST COMPANY LIMITED

25/06/2014

20/03/2015

14/12/2016

3000000000.0

IL & FS FINANCIAL CENTRE PLOT NO C22 G BLOCK BANDRA KURLA COMPLEX BANDRA EAST MUMBAI MAHARASHTRA 400051 INDIA

5

C43802255

10514981

THE RATNAKAR BANK LIMITED

30/07/2014

-

05/02/2015

500000000.0

SHAHUPURI,KOLHAPUR, KOLHAPUR MAHARASHTRA 416001 INDIA

6

C43573328

10514885

ING VYSYA BANK LIMITED

03/07/2014

-

02/02/2015

750000000.0

NARIAN MANZIL, GROUND FLOOR, SHOP NO. G1 TO G5,I FLOOR, SHOP NO.1001 TO 1007,BARAKHAMBA ROAD, NEW DELHI 110001 INDIA

7

C43150382

10522898

EXPORT IMPORT BANK OF INDIA

23/09/2014

-

22/01/2015

300000000.0

FLOOR 21; CENTRE ONE BUILDING WORLD TRADE CENTRE COMPLEX, CUFFE PARADE MUMBAI MAHARASHTRA 400005 INDIA

8

C42261693

10515202

YES BANK LIMITED

07/07/2014

-

09/01/2015

1250000000.0

9TH FLOOR, NEHRU CENTRE, DISCOVERY OF INDIA,DR. ANNIE BESANT ROAD, WORLI, MUMBAI MAHARASHTRA 400018 INDIA

 

 

CONTINGENT LIABILITIES:

 

PARTICULARS

31.03.2016

(INR in Million)

31.03.2015

(INR in Million)

Claims against the Company, disputed by the Company, not acknowledged as debts*:

 

 

Service tax

244.320

242.630

Central excise

4.650

4.730

Customs

0.080

0.830

Total

249.050

248.190

*Including claims in respect of business acquired in previous year from Jubilant Life Sciences Limited though the litigations may be continuing in the name of Jubilant Life Sciences Limited, however any liability arising in future relating to these disputes will be borne by the Company.

 

Additionally, the Company is involved in other disputes, lawsuits, claims, governmental and/ or regulatory inspections, inquiries, investigations and proceedings, including commercial matters that arise from time to time in the ordinary course of business. The Company believes that none of these matters, either individually or in aggregate, are expected to have any material adverse effect on its financial statements.

 

 

FIXED ASSETS

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 64.87

UK Pound

1

INR 90.49

Euro

1

INR 79.91

 

 

INFORMATION DETAILS

 

Information Gathered by :

AKS

 

 

Analysis Done by :

PRA

 

 

Report Prepared by :

JYTK

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.

 
 

·